If you're sensing a need to play a little less offense and a little more defense, here's three good stocks for you.
Infinity Pharmaceuticals Inc (NASDAQ: INFI) has issued data updates from two mid-stage trials for eganelisib, its oral immuno-oncology candidate. Data: 49 patients were enrolled in the MARIO-275 study designed to evaluate it as a combination therapy with Bristol-Myers Squibb Co's (NYSE: BMY) Opdivo (nivolumab) in platinum-refractory, I/O naïve patients with advanced urothelial cancer. In the combination arm, the median overall survival (mOS) in the intent to treat (ITT) population stood at 15.4
The United States' economy has largely reopened, with 57% of the population above 12 fully vaccinated against COVID-19. Let's explore some reasons why this cruise ship operator could sink your investment portfolio. As a cruise ship operator, Carnival faced the brunt of the coronavirus pandemic, especially after the Centers for Disease Control and Prevention (CDC) mandated a no-sail order that grounded the industry for most of 2020.
(Bloomberg) -- Activision Blizzard Inc. Chief Executive Officer Bobby Kotick responded to the threat of an employee walkout with an all-staff email Tuesday, apologizing and calling the company’s recent actions “tone deaf.”Employees at Activision Blizzard called for the walkout on Wednesday to protest the company’s responses to a recent sexual discrimination lawsuit and demanding more equitable treatment for underrepresented staff.In Kotick’s message, the CEO said the company had hired law firm W
(Bloomberg) -- Another double-digit share price rally could be in store for Cassava Sciences Inc. over the next month, as the biotech vies with retail trading favorites AMC Entertainment Holdings Inc. and GameStop Corp. to be the year’s top-performing stock in the Russell 3000.In the run-up to the big reveal from a mid-stage study, the 23-year old drug developer has sprinted more than 1,700% this year. On July 29, Cassava is expected to present safety and cognition data from about 50 people with
Recent acquisitions, new client wins, and product execution helped the telehealth specialist more than double its revenue year over year.
Brian Sozzi, Julie Hyman and Myles Udland discuss big tech earnings which include: Microsoft raising revenue forecast after topping earnings, Alphabet beating estimates on a strong wave of advertising growth, and Apple reporting a blowout quarter as the global chip shortage creeps up on the tech company.
Tilray earnings beat but sales just missed in the first report since the Aphria merger. Tilray stock jumped.
As the world becomes more digital, the financial sector is subject to new innovations. These two companies are changing the game.
Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced its second quarter 2021 financial and operating results. In addition, the Company increased its quarterly dividend payment by approximately 50%, accelerated its $4.5 billion net debt target timeline to the end of 2021 and set a new net debt target of $3 billion by year-end 2023, assuming $50 per bbl WTI oil and $2.75 per Mcf NYMEX natural gas prices.
Shares of Chinese electric-vehicle (EV) maker Nio (NYSE: NIO) are about 30% below January 2021 highs. Nio ES8 electric SUVs being loaded for transit to Norway. Nio has been quickly growing sales of its EVs.
Power-backup systems maker Generac reported stronger-than-expected second-quarter earnings early Wednesday, as demand picks up amid wildfires, hurricanes and other disasters. Generac stock sank. Generac Earnings Estimates: FactSet consensus was for Generac earnings per share of $2.
Investors -- and governments -- have rallied behind Novavax (NASDAQ: NVAX) since the start of the coronavirus vaccine race. Since, Novavax has lost a considerable amount of steam -- in spite of strong clinical trial data. Next week's earnings report may offer some clues.
Data software company Palantir (NYSE: PLTR) has made a name for itself, providing the U.S. government and big corporations with the tools to make data-based decisions. Palantir is finding creative ways to uncover new growth opportunities. Investors could benefit from understanding both Palantir's growth strategy and these two new ways that Palantir is applying it.
Peter Hanks, an anlyst at DailyFX, analyzes what Microsoft's earnings beat means for the future of the stock.
Boeing reported its first quarterly profit since 2019 with 737 Max production set to rise as more orders roll in.
Starbucks (SBUX) delivered record fiscal third-quarter earnings results on Tuesday, with revenue surging 78% from a year ago during the depths of the COVID-19 pandemic.
Anyone involved in the investing game will know it’s all about “stock picking.” Choosing the right stock to put your money behind is vital to ensure strong returns on an investment. Therefore, when the Wall Street pros consider a name to be a “Top Pick,” investors should take note. Using the TipRanks platform, we’ve looked up details on three stocks that have recently gotten ‘Top Pick’ designation from some of the Street’s analysts. So, let’s dive into the details and find out what makes them so
When Teladoc (NYSE: TDOC) had its initial public offering (IPO) in 2015, it was the only public company in the burgeoning industry of video-enabled doctor visits. Teladoc has been growing quickly since going public. As for the acquisition, the company bought Livongo -- a provider of digital and virtual services for patients with chronic conditions -- for $18.5 billion in cash and stock.
Crescent Point Energy Corp. ("Crescent Point" or the "Company") (TSX: CPG) (NYSE: CPG) is pleased to announce its operating and financial results for the quarter ended June 30, 2021.
Ford Motor Company (NYSE: F) will report its second-quarter earnings results after the U.S. markets close today. Wall Street analysts polled by Thomson Reuters expect Ford to report an adjusted loss of $0.10 per share on revenue of $23.84 billion, on average. Both would be improvements over the second quarter of 2020, when Ford reported a loss of $0.35 per share on revenue of just $15.95 billion following COVID-19-related factory shutdowns.